| Name | Sector |
Revenue
$mlns |
M&A Activity | Last 5 Years | ||
|---|---|---|---|---|---|---|
| Total | Buy | Sell | ||||
|
Novozymes
Public Bagsvaerd, Denmark website |
Life Science | 2,700 | 10 | 10 | - |
|
NYSE : NVO Bagsvaerd, Denmark website |
Life Science | 43,808 | 9 | 9 | - |
|
|
Genmab
NASDAQ : GMAB Copenhagen, Denmark website |
Life Science | 3,003 | 2 | 2 | - |
|
|
Galecto
NASDAQ : GLTO Copenhagen, Denmark website |
Life Science | - | 2 | 2 | - |
|
|
Ascendis Pharma
NASDAQ : ASND Hellerup, Denmark website |
Life Science | 410 | 1 | 1 | - |
|
|
Zealand Pharma
Public Soborg, Denmark website |
Life Science | 10 | 1 | 1 | - |
|
|
IO Biotech
NASDAQ : IOBT Copenhagen, Denmark website |
Life Science | 91 | - | - | - |
|
|
Evaxion
NASDAQ : EVAX Hørsholm, Denmark website |
Life Science | 3 | - | - | - |
|
Mergr was built to make it easy to understand who owns which companies — and how they got there.
Whether you're researching private equity-backed businesses, recent acquisitions, or potential targets, Mergr provides structured access to thousands of companies, investors, and ownership histories.
The platform is powerful but easy to use — so you can quickly surface relevant companies and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.